Tirzepatide is an antidiabetic medication used to treat type 2 diabetes and for weight loss. Tirzepatide is administered via subcutaneous injections. From Wikipedia
The collaboration aims to develop four GPCR-targeted small-molecule treatments, diversifying Novo Nordisk’s portfolio amid rising competition from Eli Lilly.
